Pharmaceutical preparations for the treatment of autosomal dominant polycystic kidney disease; pharmaceutical preparations for the treatment of lysosomal storage diseases
REGISTERED
on 08 Nov 2024
ENPHILBRAY
GENZYME CORPORATION
2253759 · 24 Apr 2023
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the treatment of autosomal dominant polycystic kidney disease; pharmaceutical preparations for the treatment of lysosomal storage diseases
Pharmaceutical preparations for the treatment of autosomal dominant po...
